Study #2024-1588
COG ACNS2321: Phase II trial evaluating chemotherapy followed by response-based reduced radiation therapy for patients with central nervous system germinomas
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Najat Daw Bitar
Department:
Pediatrics
For general questions about clinical trials:
1-855-319-9556
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.